Fmoc-D-Thr-OH

Fmoc-D-Thr-OH is a protected amino acid derivative in which the D-threonine side chain is retained while the α-amino group is masked by an Fmoc (9-fluorenylmethoxycarbonyl) carbamate, yielding a solid-phase peptide synthesis compatible building block. The molecule contains both an Fmoc-protected amino functionality and a free carboxylic acid (-COOH), and its threonine β-hydroxyl side chain provides a polar alcohol handle for hydrogen bonding and for chemoselective derivatization or protection strategies during peptide assembly. In synthesis workflows, the Fmoc group supports stepwise coupling by controlling amine reactivity, while the D-configured stereocenter and the unprotected side-chain hydroxyl are used to prepare peptides and peptide analogues for structure-activity studies, labeling, or conformational investigations.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP26432

CAS No:157355-81-2

Synonyms/Alias:Fmoc-D-threonine;157355-81-2;FMOC-D-THR;N-ALPHA-FMOC-D-THREONINE;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-threonine;Fmoc-D-Thr-OH;118609-38-4;N-Fmoc-D-threonine;(2R,3S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxybutanoicacid;AmbotzFAA1510;CTK8B0893;MolPort-008-267-682;ZINC1576234;7888AA;ANW-21694;CF-199;AKOS015840856;AB04101;AJ-27301;AK-81193;KB-254033;RT-012954;TR-006616;N-ALPHA-FMOC-D-THREONINE/(2R,3S);K-4945

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C19H19NO5
M.W/Mr.
341.36

Fmoc-D-Thr-OH is an Fmoc-protected D-threonine amino acid derivative featuring a chiral β-carbon and a side chain bearing a primary hydroxyl group. The molecule contains an N-(9H-fluoren-9-ylmethoxycarbonyl) protecting group on the amino functionality and a free carboxylic acid, providing a defined polarity profile suited to solid-phase and solution-phase peptide chemistry. The stereochemical configuration at the D-threonine center supports stereocontrolled incorporation into peptide sequences and threonine-derived motifs. The combination of an orthogonally removable Fmoc group and a side-chain hydroxyl enables downstream derivatization for hydrogen-bonding modulation, ester/ether formation, and selective functional group transformations.

1. Peptide Synthesis

Fmoc-D-Thr-OH is used in peptide building block preparation for both solid-phase peptide synthesis and solution-phase coupling workflows. The Fmoc carbamate protects the amino group during chain assembly while the carboxylic acid participates in standard peptide coupling chemistry, supporting reliable formation of amide bonds at the threonine residue. The D-configuration at the α-carbon allows stereochemically defined peptide analogs where D-threonine may alter backbone conformations and proteolytic stability profiles in biochemical research. The side-chain hydroxyl can remain protected or be selectively transformed after incorporation, enabling threonine-specific analog construction and controlled functional group presentation.

2. Side-Chain Functionalization

Fmoc-D-Thr-OH is applied in amino acid derivatization strategies targeting threonine side-chain hydroxyl chemistry. The free carboxylic acid and Fmoc-protected amine provide orthogonal handles for selective activation and subsequent conversion of the β-hydroxyl into esters, ethers, or other oxygen-linked functionalities. The D-stereocenter can be leveraged to generate stereochemically consistent analogs for structure-activity relationship studies, conformational tuning, and hydrogen-bonding pattern control. Functionalized derivatives prepared from Fmoc-D-Thr-OH can serve as intermediates for peptidomimetics and for constructing molecular scaffolds where hydroxyl oxygen geometry influences binding or recognition.

3. Protected Amino Acids

Fmoc-D-Thr-OH is suitable for protected amino acid synthesis workflows where orthogonal protection and stereochemical fidelity are required for downstream peptide coupling. The Fmoc group provides base-labile protection for the amino functionality, aligning with common deprotection strategies used to expose the amine for iterative chain elongation. The presence of a free carboxylic acid supports direct conversion into activated coupling species, making the compound compatible with peptide building block preparation and intermediate handling in fine chemical synthesis. The D-threonine stereochemistry enables construction of chiral peptide libraries and stereodefined intermediates for biochemical research and analytical reference materials.

4. Peptidomimetics And SAR

Fmoc-D-Thr-OH is utilized in peptidomimetic construction and medicinal chemistry-oriented SAR studies requiring incorporation of stereochemically defined threonine analogs. The Fmoc-protected amino acid format supports rapid assembly of peptide-like scaffolds that carry D-threonine at defined positions, enabling systematic evaluation of how stereochemistry and side-chain hydroxyl placement influence molecular recognition. The β-hydroxyl functionality can be retained for hydrogen-bonding interactions or converted into alternative oxygen substituents to probe binding determinants while maintaining the chiral framework. The resulting D-threonine-containing analogs can be applied as chemical biology probes, scaffold components, or structure-defined intermediates for iterative design cycles.

5. Protein Engineering

Fmoc-D-Thr-OH is used for protein engineering and chemical biology research where D-amino acid incorporation supports altered stability and controlled chemical functionality. The protected amino acid format facilitates the preparation of peptide segments and modified protein domains that include D-threonine residues at specific sequence contexts. The side-chain hydroxyl enables conjugation-compatible modification routes, including controlled derivatization prior to or after assembly into larger biomolecular constructs. The stereochemical integrity of the D-center helps maintain defined chiral presentation in engineered peptides and protein fragments used for mapping interactions, studying folding tendencies, or generating chemically addressable biomolecule variants.

6. Pharmaceutical Manufacturing Intermediates

Fmoc-D-Thr-OH is applicable to pharmaceutical intermediate preparation for manufacturing-oriented peptide and peptide-derivative processes. The Fmoc-protected amino acid structure supports established peptide coupling and deprotection logic used in industrial fine chemical synthesis of peptide building blocks and defined intermediates. The free carboxylic acid and protected amine enable conversion into process-compatible activated forms for controlled assembly steps, while the D-threonine stereochemistry supports consistent chiral outcomes across batches. The compound's functional group pattern also supports downstream derivatization routes that can be integrated into manufacturing workflows for producing stereodefined peptide analogs and related chemical entities.

Size
1 g;5 g;
InChI
1S/C19H19NO5/c1-11(21)17(18(22)23)20-19(24)25-10-16-14-8-4-2-6-12(14)13-7-3-5-9-15(13)16/h2-9,11,16-17,21H,10H2,1H3,(H,20,24)(H,22,23)/t11-,17+/m0/s1
InChI Key
OYULCCKKLJPNPU-APPDUMDISA-N
Canonical SMILES
CC(C(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)O

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisPeptide Modification ServicesPeptide Analysis ServicescGMP Peptide ServiceCustom Conjugation ServicePeptide Synthesis ServicesPeptide CDMOEpitope Mapping Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers